Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna’s AbbVie ABBV Stock Holding History

Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$436K	Buy	1,734 +32	+2%	+$6.88K	0.15%	114
2026 Q1	$370K	Hold	1,702	–	–	0.15%	118
2025 Q4	$389K	Buy	1,702 +11	+0.7%	+$2.51K	0.15%	112
2025 Q3	$392K	Hold	1,691	–	–	0.16%	104
2025 Q2	$314K	Sell	1,691 -3,619	-68%	-$673K	0.13%	111
2025 Q1	$1.11M	Hold	5,310	–	–	0.53%	59
2024 Q4	$936K	Sell	5,310 -87	-2%	-$16K	0.37%	63
2024 Q3	$1.07M	Buy	5,397 +25	+0.5%	+$4.67K	0.41%	62
2024 Q2	$921K	Buy	5,372 +62	+1%	+$10.3K	0.35%	69
2024 Q1	$927K	Sell	5,310 -1,290	-20%	-$222K	0.37%	67
2023 Q4	$1.02M	Sell	6,600 -30	-0.5%	-$4.37K	0.43%	58
2023 Q3	$988K	Buy	6,630 +30	+0.5%	+$4.4K	0.53%	58
2023 Q2	$889K	Hold	6,600	–	–	0.43%	56
2023 Q1	$1.04M	Hold	6,600	–	–	0.6%	44
2022 Q4	$1.07M	Hold	6,600	–	–	0.82%	35
2022 Q3	$886K	Sell	6,600 -3,400	-34%	-$488K	0.72%	33
2022 Q2	$1.53M	Hold	10,000	–	–	0.98%	31
2022 Q1	$1.62M	Buy	+10,000	New	+$1.45M	0.77%	34

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna's ABBV Position: Q2 2026 in Review

Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna increased its AbbVie (ABBV) stake by 1.9% in Q2 2026, buying an estimated $6.88K and bringing the position to 1,734 shares worth $436K. The position accounts for 0.15% of the portfolio, ranked #114.

Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna first reported a position in ABBV in Q1 2022 and has held it in 18 quarters since. The position peaked at $1.62M in Q1 2022. 3,517 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna held 1,734 shares of AbbVie worth $436K as of Q2 2026.
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna bought 32 AbbVie shares in Q2 2026, an estimated $6.88K.
AbbVie made up 0.15% of Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna's portfolio in Q2 2026, its #114 holding.
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna first reported a position in AbbVie in Q1 2022 and has held it in 18 quarters since.
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna's AbbVie position peaked at $1.62M in Q1 2022.
3,517 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna's 13F filing for Q2 2026, filed 21 Jul 2026.